| RS2545822092 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545822994 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2545823182 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545823444 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545823560 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy |
| RS2545823705 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545823906 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545823922 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545824104 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545824574 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545824673 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545824873 |
SZT2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2545825608 |
SZT2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS2545826385 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545826394 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS2545827197 |
SZT2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS2545827443 |
SPEG
|
Health Risk |
Pathogenic |
— |
| RS2545829648 |
SZT2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2545834731 |
ITGB4
|
Health Risk |
Likely pathogenic |
— |
| RS2545834880 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545834964 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2545835165 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545838508 |
TPO
|
Health Risk |
Pathogenic |
— |
| RS2545839250 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545841178 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545841470 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS2545841476 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545841708 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545841958 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS2545842119 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS2545848982 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545850014 |
SZT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS2545850576 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545850643 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545850999 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545851200 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545852484 |
RSPRY1
|
Health Risk |
Pathogenic |
Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome, Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome |
| RS2545852780 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS2545852869 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2545853590 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545855843 |
TPO
|
Health Risk |
Likely pathogenic |
Deficiency of iodide peroxidase, Deficiency of iodide peroxidase |
| RS2545856529 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545857117 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS2545857531 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545858260 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS2545865194 |
TMEM94
|
Health Risk |
Likely pathogenic |
TMEM94-related disorder, TMEM94-related disorder |
| RS2545865930 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545867076 |
SPEG
|
Health Risk |
Pathogenic |
SPEG-related disorder, SPEG-related disorder |
| RS2545867555 |
ITGB4
|
Health Risk |
Likely pathogenic |
ITGB4-related disorder, ITGB4-related disorder |
| RS2545867748 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545868763 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS2545868804 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545872938 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2545873293 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2545873713 |
FOXP1
|
Health Risk |
Likely pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2545875559 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545875669 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545875803 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545875886 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545876644 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS2545876679 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545876835 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS2545877072 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545877361 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545878700 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545878890 |
ITGB4
|
Health Risk |
Pathogenic |
Epidermolysis bullosa, junctional 5A |
| RS2545879408 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545880403 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2545884453 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545884988 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545885560 |
FOXP1
|
Health Risk |
Likely pathogenic |
— |
| RS2545885692 |
ITGB4
|
Health Risk |
Likely pathogenic |
Melanoma, Melanoma |
| RS2545886648 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545887085 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545887560 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2545888966 |
ITGB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Epidermolysis bullosa, junctional 5A |
| RS2545893385 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS2545893534 |
LRBA
|
Health Risk |
Likely pathogenic |
— |
| RS2545893731 |
LRBA
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS2545898782 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2545899422 |
GALK1
|
Health Risk |
Pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545899470 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545899596 |
GALK1
|
Health Risk |
Pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545899880 |
GALK1
|
Health Risk |
Pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545900132 |
GALK1
|
Health Risk |
Pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545900183 |
GALK1
|
Health Risk |
Pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545900206 |
GALK1
|
Health Risk |
Pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545900232 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545900278 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545900296 |
GALK1
|
Health Risk |
Pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545900350 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545900373 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545901248 |
SPEG
|
Health Risk |
Pathogenic |
— |
| RS2545903065 |
GALK1
|
Health Risk |
Pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545903117 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545903185 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545903420 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545903458 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545903471 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2545903484 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |